Primary sterile necrotic cells fail to cross-prime CD8+ T cells

Necrotic cells are known to activate the innate immune system and trigger inflammation by releasing damage associated molecular patterns (DAMPs). However, how necrotic cells influence the induction of antigen-specific CD8+ T cell-mediated adaptive immune responses under sterile conditions, in the absence of pathogen associated molecular patterns (PAMPs), remains poorly understood. Here, we examined antigen-specific CD8+ T-cell responses to primary sterile necrotic tumor cells both in vitro and in vivo. We found that primary necrotic cells alone fail to generate CD8+ T cell-dependent immune responses toward cell-associated antigens. We show that necrotic cells trigger CD8+ T-cell immunity only in the presence of PAMPs or analogs, such as p(dI-dC) and/or unmethylated CpG DNA. The electroporation of tumor cells with these PAMPs prior to necrosis induction triggered antigen-specific CD8+ T-cell responses through a TLR9/MyD88-dependent pathway. In addition, we found that necrotic cells contain factors that can block the cross-priming of CD8+ T cells even under non-sterile conditions and can serve as a possible mechanism of immunosuppression. These results suggest that antigen-specific CD8+ T-cell responses to primary necrotic tumor cells can be induced in the presence of PAMPs and thus have a substantial impact on the development of antitumor vaccination strategies.

[1]  B. Thompson,et al.  F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. , 2012, Immunity.

[2]  F. Di Virgilio,et al.  Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice , 2011, Science.

[3]  Masaaki Komatsu,et al.  Autophagy: Renovation of Cells and Tissues , 2011, Cell.

[4]  L. Zitvogel,et al.  How to improve the immunogenicity of chemotherapy and radiotherapy , 2011, Cancer and Metastasis Reviews.

[5]  C. Caux,et al.  CpG Promotes Cross-Presentation of Dead Cell-Associated Antigens by Pre-CD8α+ Dendritic Cells , 2011, The Journal of Immunology.

[6]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[7]  O. Kepp,et al.  Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells , 2009, Cell Death and Differentiation.

[8]  Anna M. Keller,et al.  Identification of a dendritic cell receptor that couples sensing of necrosis to immunity , 2009, Nature.

[9]  J. Yewdell,et al.  The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. , 2008, Immunity.

[10]  T. Hartung,et al.  Cellular Recognition of Trimyristoylated Peptide or Enterobacterial Lipopolysaccharide via Both TLR2 and TLR4* , 2007, Journal of Biological Chemistry.

[11]  M. Manns,et al.  Necrotic Tumor Cell Death In Vivo Impairs Tumor-Specific Immune Responses1 , 2007, The Journal of Immunology.

[12]  L. Zitvogel,et al.  Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.

[13]  C. Figdor,et al.  Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity , 2006, British Journal of Cancer.

[14]  C. Figdor,et al.  Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. , 2006, Cancer research.

[15]  B. Beutler,et al.  Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. , 2006, Immunity.

[16]  L. Zitvogel,et al.  Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death , 2005, The Journal of experimental medicine.

[17]  G. Prestwich,et al.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.

[18]  J. Yewdell The seven dirty little secrets of major histocompatibility complex class I antigen processing. , 2005, Immunological reviews.

[19]  D. Tscharke,et al.  CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates , 2004, Science.

[20]  D. Weissman,et al.  mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.

[21]  James E. Evans,et al.  Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.

[22]  M. Leist,et al.  Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells , 2003, Cell Death and Differentiation.

[23]  J. Frelinger,et al.  Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells1 , 2003, The Journal of Immunology.

[24]  Jongdae Lee,et al.  Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Manns,et al.  Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo , 2003, International journal of cancer.

[26]  R. Steinman,et al.  Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ , 2002, The Journal of experimental medicine.

[27]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[28]  Carsten J. Kirschning,et al.  The Endoplasmic Reticulum-resident Heat Shock Protein Gp96 Activates Dendritic Cells via the Toll-like Receptor 2/4 Pathway* , 2002, The Journal of Biological Chemistry.

[29]  F. Westwood,et al.  Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  Carsten J. Kirschning,et al.  HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway* , 2002, The Journal of Biological Chemistry.

[31]  G. Kroemer,et al.  Genetic analysis of the mammalian cell death machinery. , 2002, Trends in genetics : TIG.

[32]  N. Bhardwaj,et al.  Primary Tumor Tissue Lysates Are Enriched in Heat Shock Proteins and Induce the Maturation of Human Dendritic Cells1 , 2001, The Journal of Immunology.

[33]  Cevayir Coban,et al.  Genomic DNA Released by Dying Cells Induces the Maturation of APCs1 2 , 2001, The Journal of Immunology.

[34]  C. Bruyns,et al.  The P2Y11 Receptor Mediates the ATP-Induced Maturation of Human Monocyte-Derived Dendritic Cells1 , 2001, The Journal of Immunology.

[35]  C. Kurts,et al.  Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo1 , 2001, The Journal of Immunology.

[36]  W. Heath,et al.  Cross-presentation, dendritic cells, tolerance and immunity. , 2001, Annual review of immunology.

[37]  K. Rock,et al.  Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[39]  T. Mak,et al.  Executionary pathway for apoptosis: lessons from mutant mice , 2000, Cell Research.

[40]  P. Srivastava,et al.  Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. , 2000, International immunology.

[41]  H. Rammensee,et al.  The heat shock protein gp96 induces maturation of dendritic cells and down‐regulation of its receptor , 2000, European journal of immunology.

[42]  C. Klein,et al.  Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines , 2000, The Journal of experimental medicine.

[43]  C. Kurts,et al.  Characterization of the ovalbumin‐specific TCR transgenic line OT‐I: MHC elements for positive and negative selection , 2000, Immunology and cell biology.

[44]  Nina Bhardwaj,et al.  Consequences of cell death: exposure to necrotic tumor cells , 2000 .

[45]  A. Lanzavecchia,et al.  Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells , 2000, European journal of immunology.

[46]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[47]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[48]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[49]  S Oehen,et al.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.

[50]  C. Kurts,et al.  Brief Definitive Report Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction , 2022 .

[51]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[52]  M. Albert,et al.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.

[53]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[54]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[55]  S. Silagi CONTROL OF PIGMENT PRODUCTION IN MOUSE MELANOMA CELLS IN VITRO , 1969, The Journal of cell biology.